An Open-label, Multicenter, Dose-finding Study to Evaluate the Safety and Tolerability of AMG 706 or Panitumumab When Administered With Induction Chemotherapy (IC) and/or Chemo-radiotherapy (CRT) in the Treatment of Subjects With Loco-regionally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN).

Sponsor ID

20040235

Clinicaltrials.gov ID

EUCTIS ID

N/A

EudraCT ID

N/A

Study Details

Phase

Phase 1

Product

N/A

Type

Interventional

Masking

N/A

Enrollment

N/A

Additional Study Details

Primary Outcome Measures

Not Available

Secondary Outcome Measures

Not Available

Study Synopsis

Available Language(s): English

No locations found.